Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Sales | 502 | 841 | 731 | 389 | 319 |
| Cost of Goods | 998 | 853 | 568 | 251 | 174 |
| Gross Profit | -496 | 163 | 138 | 145 | 145 |
| Operating Expenses | 998 | 931 | 908 | 690 | 573 |
| Operating Income | -496 | -90 | -177 | -301 | -254 |
| Interest Expense | 29 | 29 | 28 | 0 | 0 |
| Other Income | 57 | 60 | -3 | 178 | 86 |
| Pre-tax Income | -468 | -59 | -208 | -123 | -168 |
| Income Tax | 7 | 7 | 8 | 8 | 7 |
| Net Income Continuous | -474 | -67 | -216 | -131 | -174 |
| Net Income | $-474 | $-67 | $-216 | $-131 | $-174 |
| EPS Basic Total Ops | -0.08 | -0.01 | -0.04 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.08 | -0.01 | -0.04 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.08 | -0.01 | -0.04 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.08 | -0.01 | -0.04 | -0.02 | -0.03 |
| EBITDA(a) | $-496 | $240 | $-177 | $-301 | $-254 |